Cells of the substantia nigra are compromised in Parkinson's disease and related disorders, either through an hypothesized genetically programmed apoptotic pathway, or via excessive excitation coupled to the neurophysiological functions of excitatory amino acids (EAAs). These two systems may function cooperatively, although the mechanisms are poorly understood. The proposed goal of this research to investigate this possibility by evaluating the major EAA input pathways to the zona compacta of the substantia nigra (SNc), and their synaptic relationships with dopaminergic nigrostriatal systems. Since different EAA receptor subtypes exist, it is our plan to trace the interconnections between the EAA terminal arborizations, SNc EAA receptor distribution, and nigral postsynaptic transduction/gene-expression mechanisms. Anatomic and functional characterization will be conducted via immunocytochemical and electrophysiological techniques. The second part of this project relates to the molecular genetic aspects of programmed cell death in the SNc. In acutely dissociated Snc cells, apoptosis-related gene expression will be studied by subtractive hybridization followed by detailed analysis of the sequence of events related to expression, regulation and information transduction which may be linked to ionic pathways. These studies should yield information on possible apoptotic events relevant to future investigations into the subcellular mechanisms of excitotoxicity. Molecular studies will contribute to the identification of cellular markers related to the cell death process. Electro-physiological monitoring of SNc cells in vitro could give data on possible aberrations in ionic pathways, and allow further experimental design and exploration in the quest for answers.

Project Start
1997-08-01
Project End
1998-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Morehouse School of Medicine
Department
Type
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30310
Wilson, Nana O; Solomon, Wesley; Anderson, Leonard et al. (2013) Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One 8:e60898
Igietseme, Joseph U; Omosun, Yusuf; Partin, James et al. (2013) Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J Infect Dis 207:1095-104
Wilson, Nana; Driss, Adel; Solomon, Wesley et al. (2013) CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria. PLoS One 8:e81329
Kim, Teayoun; Zhelyabovska, Olga; Liu, Jian et al. (2013) Generation of an inducible, cardiomyocyte-specific transgenic mouse model with PPAR ?/? overexpression. Methods Mol Biol 952:57-65
Shelton, Martin N; Huang, Ming-Bo; Ali, Syed A et al. (2012) Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol 86:406-19
Campbell, Patrick E; Isayev, Olexandr; Ali, Syed A et al. (2012) Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling. J Mol Model 18:4603-13
Liu, Mingli; Amodu, Audu S; Pitts, Sidney et al. (2012) Heme mediated STAT3 activation in severe malaria. PLoS One 7:e34280
Wilson, Nana O; Ceesay, Fatou K; Hibbert, Jacqueline M et al. (2012) Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. Am J Trop Med Hyg 86:936-42
Wilson, Nana O; Ceesay, Fatou K; Obed, Samuel A et al. (2011) Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. Am J Trop Med Hyg 85:12-21
Lucchi, Naomi W; Jain, Vidhan; Wilson, Nana O et al. (2011) Potential serological biomarkers of cerebral malaria. Dis Markers 31:327-35

Showing the most recent 10 out of 122 publications